Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease

Magnetic resonance imaging (MRI) studies have identified aberrant cortical structure in Alzheimer's disease (AD). The association between MRI-derived cortical morphometry measures and β-amyloid, however, remains poorly understood. In this study, we explored the potential relationship between ea...

Full description

Bibliographic Details
Main Authors: Marilyn Grand'Maison, Simone P. Zehntner, Ming-Kai Ho, François Hébert, Andrew Wood, Felix Carbonell, Alex P. Zijdenbos, Edith Hamel, Barry J. Bedell
Format: Article
Language:English
Published: Elsevier 2013-06-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996113000673
id doaj-5bb645cbe13047059ff61182188accf3
record_format Article
spelling doaj-5bb645cbe13047059ff61182188accf32021-03-22T12:39:42ZengElsevierNeurobiology of Disease1095-953X2013-06-01545967Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's diseaseMarilyn Grand'Maison0Simone P. Zehntner1Ming-Kai Ho2François Hébert3Andrew Wood4Felix Carbonell5Alex P. Zijdenbos6Edith Hamel7Barry J. Bedell8Small Animal Imaging Lab, McConnell Brain Imaging Centre, Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, QC H3A 2B4, CanadaBiospective Inc., 6100 Avenue Royalmount, Montreal, QC H4P 2R2, CanadaSmall Animal Imaging Lab, McConnell Brain Imaging Centre, Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, QC H3A 2B4, CanadaBiospective Inc., 6100 Avenue Royalmount, Montreal, QC H4P 2R2, CanadaBiospective Inc., 6100 Avenue Royalmount, Montreal, QC H4P 2R2, CanadaBiospective Inc., 6100 Avenue Royalmount, Montreal, QC H4P 2R2, CanadaBiospective Inc., 6100 Avenue Royalmount, Montreal, QC H4P 2R2, CanadaSmall Animal Imaging Lab, McConnell Brain Imaging Centre, Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, QC H3A 2B4, CanadaSmall Animal Imaging Lab, McConnell Brain Imaging Centre, Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, QC H3A 2B4, Canada; Biospective Inc., 6100 Avenue Royalmount, Montreal, QC H4P 2R2, Canada; Corresponding author at: Montreal Neurological Institute, McGill University, 3801 University Street, Room NW111, Montreal, Québec H3A 2B4, Canada. Fax: +1 514 398 6547.Magnetic resonance imaging (MRI) studies have identified aberrant cortical structure in Alzheimer's disease (AD). The association between MRI-derived cortical morphometry measures and β-amyloid, however, remains poorly understood. In this study, we explored the potential relationship between early alterations in cortical thickness and later stage β-amyloid deposition, using a novel approach, in a transgenic AD mouse model. We acquired longitudinal anatomical MRI scans from mutant amyloid precursor protein (APP) transgenic mice and age-matched wild-type mice at 1 and 3.5 months-of-age, and employed fully-automated image processing methods to derive objective, quantitative measures of cortical thickness on a region-of-interest basis. We also generated 3D quantitative immunohistochemistry (qIHC) volumes of deposited β-amyloid burden from 18 month-old transgenic mice using an automated, production-level process. These studies revealed thinner cortex in most regions in the 1 month-old transgenic mice relative to age-matched wild-types, with the exception of the frontal, perirhinal/entorhinal, posterior cingulate, and retrosplenial cortical regions. Between 1 and 3.5 months-of-age, the transgenic mice demonstrated stable or increasing cortical thickness, while the wild-type mice showed cortical thinning. Based on data from co-registered 3D MRI and qIHC volumes, we identified an association between abnormal, early, regional cortical thickness change over 2.5 months and later β-amyloid deposition. These observations suggest that the spatio-temporal pattern of early (pre-plaque) alterations in cerebral cortical structure is indicative of regional predisposition to later β-amyloid pathology in a transgenic AD mouse model.http://www.sciencedirect.com/science/article/pii/S0969996113000673Alzheimer's diseaseAnimal modelBeta-amyloidCortical thicknessQuantitative immunohistochemistryMagnetic resonance imaging
collection DOAJ
language English
format Article
sources DOAJ
author Marilyn Grand'Maison
Simone P. Zehntner
Ming-Kai Ho
François Hébert
Andrew Wood
Felix Carbonell
Alex P. Zijdenbos
Edith Hamel
Barry J. Bedell
spellingShingle Marilyn Grand'Maison
Simone P. Zehntner
Ming-Kai Ho
François Hébert
Andrew Wood
Felix Carbonell
Alex P. Zijdenbos
Edith Hamel
Barry J. Bedell
Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease
Neurobiology of Disease
Alzheimer's disease
Animal model
Beta-amyloid
Cortical thickness
Quantitative immunohistochemistry
Magnetic resonance imaging
author_facet Marilyn Grand'Maison
Simone P. Zehntner
Ming-Kai Ho
François Hébert
Andrew Wood
Felix Carbonell
Alex P. Zijdenbos
Edith Hamel
Barry J. Bedell
author_sort Marilyn Grand'Maison
title Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease
title_short Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease
title_full Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease
title_fullStr Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease
title_full_unstemmed Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease
title_sort early cortical thickness changes predict β-amyloid deposition in a mouse model of alzheimer's disease
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2013-06-01
description Magnetic resonance imaging (MRI) studies have identified aberrant cortical structure in Alzheimer's disease (AD). The association between MRI-derived cortical morphometry measures and β-amyloid, however, remains poorly understood. In this study, we explored the potential relationship between early alterations in cortical thickness and later stage β-amyloid deposition, using a novel approach, in a transgenic AD mouse model. We acquired longitudinal anatomical MRI scans from mutant amyloid precursor protein (APP) transgenic mice and age-matched wild-type mice at 1 and 3.5 months-of-age, and employed fully-automated image processing methods to derive objective, quantitative measures of cortical thickness on a region-of-interest basis. We also generated 3D quantitative immunohistochemistry (qIHC) volumes of deposited β-amyloid burden from 18 month-old transgenic mice using an automated, production-level process. These studies revealed thinner cortex in most regions in the 1 month-old transgenic mice relative to age-matched wild-types, with the exception of the frontal, perirhinal/entorhinal, posterior cingulate, and retrosplenial cortical regions. Between 1 and 3.5 months-of-age, the transgenic mice demonstrated stable or increasing cortical thickness, while the wild-type mice showed cortical thinning. Based on data from co-registered 3D MRI and qIHC volumes, we identified an association between abnormal, early, regional cortical thickness change over 2.5 months and later β-amyloid deposition. These observations suggest that the spatio-temporal pattern of early (pre-plaque) alterations in cerebral cortical structure is indicative of regional predisposition to later β-amyloid pathology in a transgenic AD mouse model.
topic Alzheimer's disease
Animal model
Beta-amyloid
Cortical thickness
Quantitative immunohistochemistry
Magnetic resonance imaging
url http://www.sciencedirect.com/science/article/pii/S0969996113000673
work_keys_str_mv AT marilyngrandmaison earlycorticalthicknesschangespredictbamyloiddepositioninamousemodelofalzheimersdisease
AT simonepzehntner earlycorticalthicknesschangespredictbamyloiddepositioninamousemodelofalzheimersdisease
AT mingkaiho earlycorticalthicknesschangespredictbamyloiddepositioninamousemodelofalzheimersdisease
AT francoishebert earlycorticalthicknesschangespredictbamyloiddepositioninamousemodelofalzheimersdisease
AT andrewwood earlycorticalthicknesschangespredictbamyloiddepositioninamousemodelofalzheimersdisease
AT felixcarbonell earlycorticalthicknesschangespredictbamyloiddepositioninamousemodelofalzheimersdisease
AT alexpzijdenbos earlycorticalthicknesschangespredictbamyloiddepositioninamousemodelofalzheimersdisease
AT edithhamel earlycorticalthicknesschangespredictbamyloiddepositioninamousemodelofalzheimersdisease
AT barryjbedell earlycorticalthicknesschangespredictbamyloiddepositioninamousemodelofalzheimersdisease
_version_ 1724208463023702016